Sanofi | Kontanter Og Tilsvarende

Cash And Equivalent Endring Dato
AbbVie USD 18.07B 4.78B 2024-03
Amgen USD 9.71B 1.24B 2024-03
AstraZeneca USD 7.84B 2B 2024-03
Bristol-Myers Squibb USD 9.33B 2.13B 2024-03
Canopy Growth CAD 170.3M 115.18M 2024-03
Catalent USD 162M 67M 2024-03
Corcept Therapeutics USD 149.75M 275.65M 2024-03
Drreddys Laboratories INR 1.02B 8.31B 2023-12
Eli Lilly USD 2.46B 79.4M 2024-03
Galapagos EUR 73.37M 93.43M 2024-03
Genmab DKK 14.67B 197M 2024-03
GlaxoSmithKline GBP 2.79B 146M 2024-03
Glaxosmithkline GBP 2.79B 146M 2024-03
J&J USD 25.47B 21.97B 2024-03
Merck USD 5.58B 3.03B 2024-03
Novartis USD 9.47B 3.92B 2024-03
Novartis USD 9.47B 3.92B 2024-03
Pacira USD 184.05M 30.75M 2024-03
Perrigo USD 651.5M 99.8M 2024-03
Pfizer USD 719M 2.43B 2024-03
Prestige Brands USD 46.47M 17.15M 2024-03
Roche Holding CHF 5.38B 1.66B 2023-12
Supernus Pharmaceuticals USD 63.4M 11.65M 2024-03
UCB EUR 861M 404M 2023-12
Zoetis USD 1.97B 66M 2024-03



Sanofi Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.